Cargando…

Killing the Invaders: NK Cell Impact in Tumors and Anti-Tumor Therapy

SIMPLE SUMMARY: NK cells are innate lymphoid cells involved in the control of tumor growth and metastatic spread. Given their significant cytolytic capacity, several promising strategies have been developed to target NK cells in cancer immunotherapy. ABSTRACT: Natural Killer cells belong to group 1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Molgora, Martina, Cortez, Victor S., Colonna, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913353/ https://www.ncbi.nlm.nih.gov/pubmed/33546248 http://dx.doi.org/10.3390/cancers13040595

Ejemplares similares

Exploring the Impact of TREM2 in Tumor-Associated Macrophages
por: Khantakova, Darya, et al.
Publicado: (2022)

IL-1R8 is a checkpoint in NK cells regulating anti-tumor and anti-viral activity
por: Molgora, Martina, et al.
Publicado: (2017)

Exploiting NK Cell Surveillance Pathways for Cancer Therapy
por: Barrow, Alexander David, et al.
Publicado: (2019)

Functional visualization of NK cell-mediated killing of metastatic single tumor cells
por: Ichise, Hiroshi, et al.
Publicado: (2022)

Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian Cancer
por: Greppi, Marco, et al.
Publicado: (2019)

Advances in NK cell therapy for brain tumors
por: Fares, Jawad, et al.
Publicado: (2023)

NK cells sense tumors, course of disease and treatments: Consequences for NK-based therapies
por: Fregni, Giulia, et al.
Publicado: (2012)

Combination Immune Therapies to Enhance Anti-Tumor Responses by NK Cells
por: Mentlik James, Ashley, et al.
Publicado: (2013)

NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?
por: Cantoni, Claudia, et al.
Publicado: (2016)

The Function of NK Cells in Tumor Metastasis and NK Cell-Based Immunotherapy
por: Yu, Yanlin
Publicado: (2023)

CAR-NK Cells Generated with mRNA-LNPs Kill Tumor Target Cells In Vitro and In Vivo
por: Golubovskaya, Vita, et al.
Publicado: (2023)

The Adverse Impact of Tumor Microenvironment on NK-Cell
por: Hu, Ziming, et al.
Publicado: (2021)

Exploiting Human NK Cells in Tumor Therapy
por: Vacca, Paola, et al.
Publicado: (2020)

Tumor spheroids accelerate persistently invading cancer cells
por: Audoin, Melanie, et al.
Publicado: (2022)

NK cell-based tumor immunotherapy
por: Zhang, Hao, et al.
Publicado: (2023)

Dysregulation of DNAM-1-Mediated NK Cell Anti-Cancer Responses in the Tumor Microenvironment
por: Paolini, Rossella, et al.
Publicado: (2023)

CAR-NK Cells in the Treatment of Solid Tumors
por: Wrona, Ewa, et al.
Publicado: (2021)

“Stealth” tumors: Breast cancer cells shun NK-cells anti-tumor immunity
por: Mamessier, Emilie, et al.
Publicado: (2012)

Large-scale Isolation of Exosomes Derived from NK Cells for Anti-tumor Therapy
por: Luo, Heyong, et al.
Publicado: (2023)

3D spheroid culture to examine adaptive therapy response in invading tumor cells
por: Weiss, Felix, et al.
Publicado: (2023)

Nanotechnology for the detection and kill of circulating tumor cells
por: Gao, Yang, et al.
Publicado: (2014)

EGFR-Targeted Granzyme B Expressed in NK Cells Enhances Natural Cytotoxicity and Mediates Specific Killing of Tumor Cells
por: Oberoi, Pranav, et al.
Publicado: (2013)

Melanoma-associated fibroblasts decrease tumor cell susceptibility to NK cell-mediated killing through matrix-metalloproteinases secretion
por: Ziani, Linda, et al.
Publicado: (2017)

Engineering Anti-Tumor Monoclonal Antibodies and Fc Receptors to Enhance ADCC by Human NK Cells
por: Dixon, Kate J., et al.
Publicado: (2021)

Cytokine engineered NK-92 therapy to improve persistence and anti-tumor activity
por: Shin, Hyun Young, et al.
Publicado: (2023)

NK Cell-Fc Receptors Advance Tumor Immunotherapy
por: Sanseviero, Emilio
Publicado: (2019)

The Smac Mimetic BV6 Improves NK Cell-Mediated Killing of Rhabdomyosarcoma Cells by Simultaneously Targeting Tumor and Effector Cells
por: Fischer, Kyra, et al.
Publicado: (2017)

Macrophages Help NK Cells to Attack Tumor Cells by Stimulatory NKG2D Ligand but Protect Themselves from NK Killing by Inhibitory Ligand Qa-1
por: Zhou, Zhixia, et al.
Publicado: (2012)

Targeted Therapies: Friends or Foes for Patient’s NK Cell-Mediated Tumor Immune-Surveillance?
por: Damele, Laura, et al.
Publicado: (2020)

Refining kill-trap networks for the control of small mammalian predators in invaded ecosystems
por: Gormley, Andrew M., et al.
Publicado: (2020)

Size Matters: The Functional Role of the CEACAM1 Isoform Signature and Its Impact for NK Cell-Mediated Killing in Melanoma
por: Helfrich, Iris, et al.
Publicado: (2019)

NK cells specifically TCR-dressed to kill cancer cells
por: Mensali, Nadia, et al.
Publicado: (2019)

Revisiting the Prominent Anti-Tumoral Potential of Pre-mNK Cells
por: Guimont-Desrochers, Fanny, et al.
Publicado: (2013)

Pediatric Tumors-Mediated Inhibitory Effect on NK Cells: The Case of Neuroblastoma and Wilms’ Tumors
por: Pelosi, Andrea, et al.
Publicado: (2021)

Importance of T, NK, CAR T and CAR NK Cell Metabolic Fitness for Effective Anti-Cancer Therapy: A Continuous Learning Process Allowing the Optimization of T, NK and CAR-Based Anti-Cancer Therapies
por: Krug, Adrien, et al.
Publicado: (2021)

Updates in the Development of ImmunoRNases for the Selective Killing of Tumor Cells
por: Jordaan, Sandra, et al.
Publicado: (2018)

Fine-Tuning Tumor Endothelial Cells to Selectively Kill Cancer
por: Uldry, Emilie, et al.
Publicado: (2017)

Overcoming tumor resistance mechanisms in CAR-NK cell therapy
por: Valeri, Antonio, et al.
Publicado: (2022)

NK Cell Anti-Tumor Surveillance in a Myeloid Cell-Shaped Environment
por: Russo, Eleonora, et al.
Publicado: (2021)

Tumor-killing DCs
por: Bashyam, Hema
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_epmimsov5o4bi8a964ph7r8g9v